Top Story
Enliven Therapeutics Inc (NASDAQ:ELVN): Buy, Sell Or Hold At $22.65?
In last trading session, Enliven Therapeutics Inc (NASDAQ:ELVN) saw 0.48 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price
